Inhibition of plasma lipid peroxidation by anti-atherogenic antioxidant BO-653, 2,3-dihydro-5-hydroxy-4,6-di-tert-butyl-2,2-dipentylbenzofuran
Authors:
- Yasukazu YoshidaYYYasukazu Yoshida
- Etsuo NikiENEtsuo Niki
- 1 September 2004
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 68 (5) , 813-818
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Antioxidants and atherosclerosisBiochemical Society Transactions, 2004
- Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trialsThe Lancet, 2003
- Design and Synthesis of 4,6-Di-tert-butyl-2,3-dihydro-5-benzofuranols as a Novel Series of Antiatherogenic AntioxidantsJournal of Medicinal Chemistry, 2003
- Is the Oxidative Modification Hypothesis Relevant to Human Atherosclerosis?Circulation, 2002
- The 80th Anniversary of Vitamin E: Beyond Its Antioxidant PropertiesBiological Chemistry, 2002
- Clinical Trials Testing Cardiovascular Benefits of Antioxidant SupplementationFree Radical Research, 2002
- Is the Emperor Wearing Clothes?Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Is there a vitamin E paradox?Current Opinion in Lipidology, 2001
- Molecular action of vitamin E in lipoprotein oxidation:Free Radical Biology and Medicine, 2000
- 2,3-Dihydro-5-hydroxy-2,2-dipentyl-4,6-di-tert-butylbenzofuran: Design and Evaluation as a Novel Radical-Scavenging Antioxidant against Lipid PeroxidationArchives of Biochemistry and Biophysics, 1997